Products / Mod GRF 1-29
Mod GRF 1-29
As a GHRH analogue, Mod GRF 1-29 (CJC-1295 without DAC) acts on receptors at the pituitary gland to stimulate the release of Human Growth Hormone. Mod GRF 1-29 acts upon receptors located in the anterior pituitary gland, and signals the pituitary gland to increase Human Growth Hormone production and cause a release of massive quantities of Human Growth Hormone in a pulsatile manner.
THIS PRODUCT IS FOR RESEARCH PURPOSES ONLY.
Mod GRF 1-29 is a peptide hormone (also known as a protein hormone) that was developed in Canada and first mentioned in medical literature in 2005. It is a protein that is 29 amino acids long and is a GHRH analogue. As a GHRH analogue, Mod GRF 1-29 (CJC-1295 without DAC) acts on receptors at the pituitary gland to stimulate the release of Human Growth Hormone. Mod GRF 1-29 acts upon receptors located in the anterior pituitary gland, and signals the pituitary gland to increase Human Growth Hormone production and cause a release of massive quantities of Human Growth Hormone in a pulsatile manner.
The effects of Mod GRF 1-29 are very similar from what would be expected from synthetic HGH administration over the long term (see the Human Growth Hormone profile here), although the amount of time that the released human growth hormone will remain in circulation is of a far less amount of time than synthetic Human Growth Hormone does.
Therefore, multiple applications of Mod GRF 1-29 is recommended throughout the day in order to simulate Human Growth Hormone levels that remain high on a constant basis. Mod GRF 1-29 (CJC-1295 without DAC) is commonly combined with a Ghrelin mimetic (also known as a GHRP – Growth Hormone Releasing Hexapeptide), such as GHRP-6, GHRP-2, Hexarelin, or Ipamorelin in order to initiate and amplify a greater pulse of HGH from the pituitary compared to Mod GRF 1-29 used solitarily on its own.
The effects of a GHRH analogue (such as Mod GRF 1-29) and a Ghrelin mimetic (a GHRP such as GHRP-6 or Ipamorelin) are synergistic and amplify the release of HGH.
Mod GRF 1-29 is a sterile, non-pyrogenic, white lyophilized powder intended for subcutneous or intramuscular injection, after reconstitution with sterile Water for Injection (0,3% m-Cresol).
+ Mechanism of action
As a result Mod GRF 1-29 Therapy, the increased volume of human growth hormone (hGH) secreted by the stimulated pituitary gland is converted by the liver into IGF-1.
The increased amount of IGF-1 in the blood stream results an increase in metabolism and growth of new cells within the body's organs and bones. This treatment is prescribed for unlabeled use in adults to increase lean muscle mass, reduce body fat, increase bone density, enhance the immune system, and strengthen the heart, as well as, other organs of the body.
Since the increased volume of human growth hormone is produced by the body's pituitary gland, the body's endocrine system will not allow more growth hormone to be produced by the Mod GRF 1-29 stimulation of the pituitary than the body can safely process within the endocrine self-monitoring system.
Positive reuslts of Mod GRF 1-29 is very similar to recombinant human growth hormone therapy results:
- Increases the development of lean body mass through the development of new muscle cells
- Reduces body fat through lipolysis
- Increases energy and vitality
- Increases strength
- Increases endurance
- Accelerates healing from wounds or surgery
- Strengthens the heart
- Enhances the immune system
- Increases IGF-1 production
- Improves sleep quality
- Increases calcium retention, and strengthens and increases the mineralization of bone or bone density.
- Increases protein synthesis and stimulates the growth of all internal organs except the brain.
+ Adverse reaction
- Difficulty Swallowing
- Temporary Redness of Face and Neck
- Head Pain
+ Instructions for reconstitution
The injection is given into the sub-cutaneous layer which includes adipose tissue (fat).
If you are using insulin syringes which have short needles, you will need to enter the skin at 90°. to the skin, otherwise you can inject as shown in the illustration above with a 29 or 30 gauge, 0.5" needle.
Recommended dosage of Mod GRF 1-29: 200 – 500 mg once per day.
- This product can be used not more than 3 years from the production date (see box).
- After reconstitution, may be stored for a maximum of 14 days in a refrigerator at 2°C – 8°C.
- Store vials in an upright position.
- Store in a refrigerator (2°C – 8°C). Keep in the outer carton in order to protect from light.
- For one month can be stored at room temperature.